PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+18.66%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.23B
AUM Growth
+$1.23B
(+11%)
Cap. Flow
+$21.3M
Cap. Flow
% of AUM
1.73%
Top 10 Holdings %
Top 10 Hldgs %
49.61%
Holding
221
New
49
Increased
36
Reduced
30
Closed
52
Top Buys
| 1 |
NXTM
NxStage Medical Inc.
NXTM
|
$30M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$25.3M |
| 3 |
STJ
St Jude Medical
STJ
|
$18.2M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$15.1M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$10.1M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$41.5M |
| 2 |
Humana
HUM
|
$20.1M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$11.8M |
| 4 |
Baxter International
BAX
|
$9.04M |
| 5 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$7.9M |
Sector Composition
| 1 | Healthcare | 89.18% |
| 2 | Consumer Discretionary | 0.09% |
| 3 | Consumer Staples | 0.05% |
| 4 | Financials | 0.04% |
| 5 | Industrials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $127M | 8.82% | 2,797,967 +77,000 | +3% | +$3.5M |
|
|
TSRO
2
DELISTED
TESARO, Inc.
TSRO
| $96.1M | 6.66% | 1,143,615 +44,956 | +4% | +$3.78M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $83.2M | 5.77% | 15,239,444 | – | – |
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $71.8M | 4.98% | 3,767,316 -65,812 | -2% | -$1.26M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $58.4M | 4.05% | 3,279,380 +280,000 | +9% | +$4.99M |
|
|
MDVN
6
DELISTED
MEDIVATION, INC.
MDVN
| $45.8M | 3.18% | 760,000 +420,000 | +124% | +$25.3M |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $36.6M | 2.54% | 2,207,668 +910,200 | +70% | +$15.1M |
|
|
ARAV
8
DELISTED
Aravive, Inc. Common Stock
ARAV
| $31.4M | 2.17% | 2,835,754 | – | – |
|
|
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
| $30M | 2.08% | +1,382,410 | New | +$30M |
|
10
Iovance Biotherapeutics
IOVA
$807M
| $29.3M | 2.03% | 3,611,976 +824,720 | +30% | +$6.68M |
|
11
Xencor
XNCR
$580M
| $29M | 2.01% | 1,529,574 -275,210 | -15% | -$5.23M |
|
|
NVRO
12
DELISTED
NEVRO CORP.
NVRO
| $26.9M | 1.87% | 365,229 +16,629 | +5% | +$1.23M |
|
|
CPXX
13
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $25.3M | 1.75% | 838,400 -261,600 | -24% | -$7.9M |
|
|
LJPC
14
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $21.3M | 1.48% | 1,332,815 +633,300 | +91% | +$10.1M |
|
|
XLRN
15
DELISTED
Acceleron Pharma Inc.
XLRN
| $20.5M | 1.42% | 603,036 -200,000 | -25% | -$6.8M |
|
|
STJ
16
DELISTED
St Jude Medical
STJ
| $18.2M | 1.26% | +233,000 | New | +$18.2M |
|
|
DBVT
17
DBV Technologies
DBVT
$264M
| $17.8M | 1.24% | 546,696 +130,000 | +31% | +$4.24M |
|
|
QTNT
18
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $17.4M | 1.21% | 2,249,067 +60,000 | +3% | +$465K |
|
19
Evolent Health
EVH
$1.12B
| $16.8M | 1.16% | 873,064 +254,134 | +41% | +$4.88M |
|
20
Talphera
TLPH
$11.1M
| $16.1M | 1.12% | 5,995,760 | – | – |
|
|
DERM
21
DELISTED
Dermira, Inc.
DERM
| $13.5M | 0.94% | 462,000 -50,000 | -10% | -$1.46M |
|
|
VBIV
22
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $12.1M | 0.84% | 3,058,433 -201,923 | -6% | -$798K |
|
23
Assertio
ASRT
$80.4M
| $11.7M | 0.81% | 600,000 -50,000 | -8% | -$977K |
|
|
EGRX
24
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $11.6M | 0.81% | 300,000 +112,785 | +60% | +$4.37M |
|
25
Vertex Pharmaceuticals
VRTX
$100B
| $11.2M | 0.78% | 130,000 -30,000 | -19% | -$2.58M |
|